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Sleep dysfunction and stress susceptibility are
comorbid complex traits that often precede and
predispose patients to a variety of neuropsychiatric
diseases. Here, we demonstrate multilevel organiza-
tions of genetic landscape, candidate genes, and
molecular networks associated with 328 stress and
sleep traits in a chronically stressed population of
338 (C57BL/6J 3 A/J) F2 mice. We constructed
striatal gene co-expression networks, revealing
functionally and cell-type-specific gene co-regula-
tions important for stress and sleep. Using a com-
posite ranking system, we identified network mod-
ules most relevant for 15 independent phenotypic
categories, highlighting a mitochondria/synaptic
module that links sleep and stress. The key network
regulators of this module are overrepresented with
genes implicated in neuropsychiatric diseases. Our
work suggests that the interplay among sleep,
stress, and neuropathology emerges from genetic
influences on gene expression and their collective
organization through complex molecular networks,
providing a framework for interrogating the mecha-
nisms underlying sleep, stress susceptibility, and
related neuropsychiatric disorders.INTRODUCTION
Both acute and chronic stress modulate many aspects of brain
function, including cognition, emotion, behavior, and sleep
(Lupien et al., 2009). At the same time, stress-susceptible neu-
robehavioral functions also interact with one another, exerting
a complex influence on an organism’s responses to stress
(Martinez-Gonzalez et al., 2004; Minkel et al., 2012). In hu-
mans, stress susceptibility is characteristic of a range ofneurological and psychiatric disorders (Lupien et al., 2009),
many of which are also comorbid with sleep disturbances
(Goldstein and Walker, 2014). In addition, sleep loss during
stressful periods exacerbates the risk of neurobehavioral
impairment, psychiatric distress, and the development of
depression later in life (Breslau et al., 1996; Chang et al.,
1997). Despite the breadth of evidence documenting the inter-
actions between stress and sleep, the genetic and molecular
mechanisms underlying these interactions remain largely un-
clear. Both stress responses and sleep regulation are under
strong genetic control (Feder et al., 2009; O’Hara et al.,
2007), and a number of genes regulating sleep also contribute
to stress adaptation and related psychiatric disorders (Chen
et al., 2006; Turek, 2007; Yu et al., 2012). Although these find-
ings point toward common molecular mechanisms underlying
stress susceptibility and sleep, a comprehensive understand-
ing of the molecular and genetic basis for these overlapping
phenotypes remains lacking.
A systems approach is necessary to understand how multi-
ple genetic factors interact in networks and contribute to the
emergence of complex traits, including stress and sleep. Pre-
viously, such approaches have helped provide insights into
both fundamental biological processes (Archer et al., 2014;
Millstein et al., 2011; Zhu et al., 2012) and complex diseases
(Chen et al., 2008; Emilsson et al., 2008; Wang et al., 2012;
Zhang et al., 2013). A comprehensive analysis describing the
interactions between stress and sleep has not previously
been reported, and there are only a few examples demon-
strating molecular mechanisms common to stress and sleep.
Here, we address these issues by presenting a large dataset
comprising 328 stress- and sleep-related phenotypes
measured in a chronically stressed F2 mouse population (n =
338) derived from C57BL/6J (B6) and A/J. To interrogate the
possible common genetic factors underlying these stress
and sleep phenotypes, we collected genotypes at 781 infor-
mative SNP markers throughout the genome. In a randomly
selected subpopulation of 100 F2 mice, we performed RNA-
Seq gene expression profiling of the striatum, a brain region
particularly important for stress adaptation (Ahmad et al.,Cell Reports 11, 835–848, May 5, 2015 ª2015 The Authors 835
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Figure 1. Experimental Design and Analytic Approach
A population of (B6 3 A/J) F2 mice underwent a chronic unpredictable stress protocol, data collected during which enables modeling of genetic and molecular
networks underlying responses to these stresses.
(A) The sequence of chronic unpredictable stress treatments and phenotypic data collection (see Supplemental Experimental Procedures for details).
(B) Schematic diagram of the molecular and physiological data collection and integrative analysis.2010; Rossi et al., 2009), sleep-wake regulation (Earley et al.,
2013; Kim et al., 2010; Lazarus et al., 2012; Qiu et al., 2010;
Stoffers et al., 2013), and neuropsychiatric diseases (Shep-
herd, 2013; Tritsch and Sabatini, 2012; van den Heuvel
et al., 2010). Given its important roles in sleep, stress, and dis-
ease, the striatum is ideal for investigating common molecular
networks underlying sleep and stress traits. With extensive
genotypic, molecular, and phenotypic assays, we utilize an
integrative, multiscale systems approach to characterize the
genetic landscape, candidate causal genes, and gene tran-
scriptional networks shared by stress and sleep traits. We
also report that genes implicated in neuropsychiatric disorders
are overrepresented in key regulators of stress-sleep gene
networks, providing a potential molecular basis for the comor-
bidity of stress, sleep, and neuropathologies. Our systems
analysis provides a framework for identifying and prioritizing
pathways and therapeutic mechanisms associated with
abnormal stress responses and altered sleep and offers bio-
logical insights into the roles of stress and sleep in neuropsy-
chiatric pathophysiology.
RESULTS
A (B6 3 A/J) F2 Mouse Population Models Complex
Interactions between Stress and Sleep
A genetically segregating population of 338 (B6 3 A/J) F2 male
mice was subjected to a chronic, unpredictable stress schedule
(Figure 1), during which we measured multiple stress-related
behavioral and physiological phenotypes. Mice were then surgi-
cally implanted with electroencephalography (EEG) and electro-
myography (EMG) electrodes to record sleep/wake states. Upon
euthanasia, serological parameters and tissue/organ weights836 Cell Reports 11, 835–848, May 5, 2015 ª2015 The Authorswere also obtained. We selected 328 phenotypic measurements
with large variance in this population for analysis (Figure S1), and
we grouped these phenotypes into 29 broad categories (full list in
Table S1).
We identified correlations between phenotypes using Spear-
man’s rho and assessed false discovery rates (FDRs) using the
Benjamini-Hochberg procedure (Figure 2; Table S2). We
observed associations between traits within the same pheno-
typic categories, as well as across different categories. At
FDR < 0.10, we identified 3,491 pairs of significantly correlated
phenotypes. As expected, strong correlations between pheno-
types within the same category are prevalent, confirming the
overall quality of the phenotypic measurements and categori-
cal groupings. In addition, many known interactions between
distinct aspects of stress and sleep biology were observed.
This includes well-known physiological relationships, such as
body weight measurements and plasma glucose levels (Fig-
ures 2C and 2G), as well as previously reported associations
between sleep and stress traits, such as conditioned fear
and REM sleep (Figures 2B and 2F) (Menz et al., 2013; Polta
et al., 2013). Other phenotypic relationships were also
observed. For instance, corticosterone levels at 60 min into
the third (i.e., last) exposure of a 3-day social defeat proce-
dure were specifically correlated with EEG theta I (4–8 Hz)
and theta II (8–11 Hz) power densities in REM sleep measured
across multiple conditions (Figures 2D and 2H). This compre-
hensive phenotypic dataset models interactions between
stress and sleep, providing an opportunity to study genetic
and molecular mechanisms underlying stress, sleep, and their
interactions. Phenotypic correlation data are available in its
entirety to facilitate future study of additional phenotypic rela-
tionships (Table S2).
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Figure 2. Phenotypic Interactions Observed in the Chronically Stressed (B6 3 A/J) F2 Mice
(A–D) Correlation coefficients between pairs of phenotypes. The phenotypes were ordered according to their phenotypic categories.
(E–H) Statistical significance of observed associations. The phenotypes were ordered exactly the same as in (A–D).
BL, baseline; SDR, sleep deprivation recovery; Rst, after restraint stress; AUC, area under the curve. Note that 93 sleepmeasurements that were not grouped into
any of the sleep categories are not presented here, but are included in Table S2.A Stress-Modulated Dynamic Genetic Landscape
Reveals Linked Genetic Control of Stress and Sleep
Phenotypes
To reveal the genetic landscape of stress and sleep biology, we
mapped quantitative trait loci (QTL) that regulate stress and
sleep phenotypes. The dataset was permuted 1,000 times to es-
timate the FDR. At a permissive FDR < 0.2 (LOD >3.53), we un-
covered 143 QTL for the set of 328 stress and sleep phenotypes
(Figure 3A; Table S3). We confirmed a number of QTL that were
previously identified using genetically diverse mouse popula-
tions derived from B6 and A/J. These include a chromosome 1
(Chr.1) QTL (peaking at 70–80 cM) influencing open field activ-
ities (Gershenfeld and Paul, 1997), a Chr.1 QTL (peaking at75 cM) for body weight (Zhang and Gershenfeld, 2003), and
a Chr.7 QTL (peaking at 50 cM) co-localized with the albino
(Tyr) locus influencing conditioned fear (Ponder et al., 2008).
Interestingly, we identified a number of QTL that were not pre-
viously detected when the same phenotypes were studied using
unstressed B6 3 A/J populations. Notably, the most significant
QTL (LOD = 13.4) identified in our chronically stressed mice is
located at 69.58 cM on Chr.4, which strongly influenced the
plasma thyroid-stimulating hormone (TSH) levels measured at
euthanasia (Figure 3B). Median TSH levels in mice with the ho-
mozygous B6 genotype at the QTL were twice as high as in
mice with the homozygous A/J genotype (Figure 3C). This QTL
was not detected in a recent study of unstressed B6 3 A/JCell Reports 11, 835–848, May 5, 2015 ª2015 The Authors 837
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Figure 3. Identification of QTL that Influence Stress and Sleep Phenotypes
(A) Genetic landscape of stress and sleep. Genomic locations of the 142 identified QTL (FDR < 0.2) are shown (also see Table S3). BL, baseline; SDR, sleep
deprivation recovery; Rst, after restraint stress.
(B) A highly significant QTL for plasma TSH level on Chr.4. LOD, log of odds.
(C) Median ± interquartile range of plasma TSH level as a function of genotype at rs4224864, the most strongly associated SNP in the Chr.4 QTL region.
(D) Distinct QTL were linked to blood pressure measured at different times of the chronic stress protocol.
(E) Baseline plasma glucose levels were linked to QTL with consistent effect throughout the chronic stress treatment as well as QTL specific to different stages of
the protocol. Note that while a 6-hr fasting procedure preceded the glucose tolerance test and the glucosemeasurement at time 0 (i.e., week 7), it did not appear
to have a significant effect on the genetic control of glucose, as it did not result in presence or absence of a QTL specific to the baseline glucose measurement at
week 7. The most distinct genetic regulations of baseline glucose levels were observed between week 2 (i.e., most naive) and weeks 12 and 13 (i.e., most
experienced).recombinant inbredmice (McLachlan et al., 2014). As prior expo-
sures to stress are known to modulate the activity of the hypo-
thalamic-pituitary-thyroid axis and the TSH profile (Armario
et al., 1993), our results may suggest that TSH levels are regu-
lated by an interaction between the Chr.4 QTL and chronic stress
exposure.
To demonstrate further how prior stress exposure may modu-
late the genetic control of physiological parameters, we investi-
gated repeated measures of phenotypes across the chronic
stress protocol. Blood pressure was measured at weeks 1, 4,
and 7 (Figure 1A). Significant phenotypic correlations were
observed between week 1 and week 4 measurements as well
as between week 4 and week 7 measurements, but not between
week 1 and week 7 measurements (Table S2). Interestingly, this
observation is accompanied by the involvement of distinct QTL
(Figure 3D). At week 1, blood pressure was influenced by a
QTL located on the distal portion of Chr.2, while a significant838 Cell Reports 11, 835–848, May 5, 2015 ª2015 The AuthorsQTL on Chr.14 and a suggestive QTL on the proximal portion
of Chr.2 were identified at week 7. No significant QTL at FDR <
0.2 was found at week 4. We noticed a similar phenomenon for
baseline plasma glucose levels in the absence of acute stress
(Figure 3E). These data suggest that even basic physiological pa-
rameters are regulated by complex genetic architecture and that
such regulation is highly susceptible to prior stress experiences.
The genetic landscape of stress and sleep revealed a number
of co-localized QTL influencing distinct phenotypic categories
(Figure 3A). Among the 143 significant QTL, 83 were mapped
to a locus less than 10 cM from a QTL for a phenotype of a
different category. For example, a cluster on Chr.1 includes
QTL that influence open field activities, body weight, a baseline
NREM trait, and a forced swim test measure (Figure 3A; Table
S3). Furthermore, QTL for conditioned fear on Chr.7 co-localize
not only with the albino locus, but also with loci influencing
open field activities, corticosterone levels during restraint stress,
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Figure 4. A Network View of Striatal Genes Causal to Selected Behavioral and Sleep Phenotypes
Circles represent genes and squares represent phenotypic categories. The circle is sized in proportion to the number of phenotypes for which the gene tests
causal. Circles and squares are colored according to phenotype categories, with colors assigned to genes from the category of the phenotypes for which the
genes test causal. The five pink circles represent genes causal to phenotypes of multiple distinct categories. (Insert) The number of genes found causal to at least
one phenotype in each category. BL, baseline; SDR, sleep deprivation recovery; Rst, after restraint stress. See Table S4 for the full list.and sleep parameters both under baseline conditions and after
restraint stress. In summary, our analysis characterizes a rich ge-
netic landscape and identifies many co-localized QTL that may
underlie the interactions between stress and sleep and their ef-
fects on other behavioral and physiological parameters.
Identification of Candidate Causal Genes Underlying
Stress and Sleep QTL
Limited by the number of meiotic recombinations, a QTL identi-
fied using 300 F2 mice typically spans a 20-cM genomic re-
gion, harboring hundreds of genes (Li et al., 2005). To identify
candidate genes underlying the sleep and stress QTL, we inte-
grated the QTL data with RNA-seq expression data of 26,927
striatal genes and associated these molecular data to the 15
phenotype categories (Figure 4) that are known to be influencedby the striatum. We focused on phenotypic QTL that overlapped
with loci regulating gene expression (i.e., eQTL; see Supple-
mental Experimental Procedures) and utilized conditional inde-
pendence models to determine whether expression variation of
the gene mediates the QTL effect and causes phenotypic varia-
tions (Millstein et al., 2009; Schadt et al., 2005). This causality
test has successfully identified causal genes for complex sleep
traits (Millstein et al., 2011) that were later pharmacologically
validated (Brunner et al., 2011).
In this analysis, we identified 92 causal genes at p < 0.05 (Ta-
ble S4), several of which have already been well supported. For
example, somatostatin signaling is known to modulate anxiety-
like behaviors and adaptive responses to stress (Stengel et al.,
2013), and we identified Sstr3 (somatostatin receptor 3) as a
causal gene for the number of entries into the center of open fieldCell Reports 11, 835–848, May 5, 2015 ª2015 The Authors 839
arena. Our analysis also reveals many other causal candidates,
some of which are causal for several traits. For example,
Arhgef17 is one of 28 genes that are relevant to multiple pheno-
types (Figure 4), testing causal for four conditioned fear mea-
sures. Arhgef17 encodes a RhoGEF, which regulates Rho
GTPase and downstream kinases, a signaling pathway known
to affect conditioned fearmemory (Lamprecht et al., 2002). Taken
together, the causality test revealed a large number of high-pro-
file candidate genes linking genetic variability to functional con-
sequences in sleep and stress-related affective behaviors.
In addition, five genes are causal for phenotypes frommultiple
categories (Figure 4). For instance, Aldh1a1was found causal for
baseline sleep fragmentation and state amount measures.
Aldh1a1 encodes an aldehyde dehydrogenase important for
the synthesis of retinoic acid (Fan et al., 2003), a molecule
involved in sleep/wake regulation (Kitaoka et al., 2011). Interest-
ingly, the causality test identified only one gene, Uvrag (UV radi-
ation resistance associated gene), that directly links sleep and
stress-related behavioral phenotypes. Uvrag tested causal for
three conditioned fear traits and two baseline sleep fragmenta-
tion phenotypes in our experiment. Though its role in the central
nervous system remains unclear, it responds to various cellular
stresses, maintains chromosomal stability, and promotes auto-
phagy (Liang et al., 2006; Zhao et al., 2012). While our causality
analysis uncovered causal genes relevant to particular traits, it
identified few pleotropic causal genes. This suggested that anal-
ysis on the level of gene networks rather than individual genes
was needed to sufficiently capture themolecular relationship be-
tween concomitant stress and sleep phenotypes.
Network Organization of Striatal Gene Expression
Exhibits Functional and Cell-type Specificity
We constructed co-expression networks for the striatum of the
(B63 A/J) F2 mice and identified 62 independent transcriptional
modules (Figure 5A), each namedwith an arbitrarily assigned co-
lor. Twenty-eight modules are enriched for genes in specific bio-
logical pathways and gene ontology (GO) functional groups
(Table S5). Transcriptional co-expression of genes suggest
similar regulatory control (Zhang and Horvath, 2005), and we
identified many co-regulatory relationships between known
genes of interest and other gene groups. For example, the In-
dianred4 module includes four genes commonly associated
with the molecular circadian pathway, Csnk1e, Arntl, Cry1, and
Hdac3. Interestingly, this module is functionally enriched for
chaperone (p = 3.36 3 105, 3.89x) and stress response (p =
3.6 3 105, 7.32x) GO categories and includes a number of
heat shock proteins traditionally implicated in disease pathways.
These relationships suggest that seemingly diverse molecular
pathwaysmay be under similar regulatory control in the striatum.
Using cell-type-specific gene signatures from the Allen Brain
Atlas (Lein et al., 2007), we also identified several cell-type-spe-
cific modules, including an oligodendrocyte-enriched Darkolive-
green module (p = 2.8 3 1064, 54.3x) and a neuron-enriched
Turquoise module (p = 8.1 3 104, 2.24x). Previous studies
have described the functional and pathophysiological impor-
tance of cell-type specific modules in the human brain (Oldham
et al., 2008; Zhang et al., 2013), so we considered thesemodules
particularly interesting candidates for downstream analysis.840 Cell Reports 11, 835–848, May 5, 2015 ª2015 The AuthorsStriatal Gene Co-expression Modules Link Distinct
Aspects of Sleep and Stress Biology
Genetic variability and its effect on gene expression contribute to
both module organization and phenotypic segregation in our
chronically stressed mice. Our causality test results suggest
that it is difficult to link complex phenotypes through single pleio-
tropic genes and that a network-based approach may help
better understand common molecular bases linking complex
phenotypes. By correlating modules with phenotypes, we iden-
tified specific traits most relevant to striatal co-expression mod-
ules. Previous efforts have focused on relating modules to a
single class of traits (Zhang et al., 2013), but our extensive phe-
notyping assays enabled us to identify module-phenotype asso-
ciations in 15 independent trait categories (Figure 5B). We
rankedmodule relevance for each phenotype category and iden-
tified modules shared by multiple phenotypic classes (see Sup-
plemental Experimental Procedures and Table S5).
Module ranking across phenotypic categories reveals
numerous relationships between distinct aspects of stress re-
sponses and sleep. For example, the Turquoise module ranks
first for novel environment behavioral responses and third for
REM traits after restraint stress, giving it the highest composite
ranking for these traits (Figure 5C). Interestingly, it is highly en-
riched with causal genes for behavioral responses to novel envi-
ronment (15 of the 23 causal genes; p = 2.9 3 107, 3.9x). This
result complements the module ranking by providing strong
gene-level evidence for its relationship to novel environment
stress. The Turquoise module is also enriched with genes in
the mitochondrial membrane (p = 1.23 3 1012, 1.89x) and syn-
aptic (e.g., a variety of neurotransmitter receptors; p = 1.01 3
109, 1.85x) GO categories, which is consistent with its
neuron-specific gene signature. A growing body of evidence
suggests that mitochondria modulate synaptic plasticity,
contribute tomany CNS diseases, and can serve as an important
therapeutic target (Manji et al., 2012). Our results support the hy-
pothesis that mitochondria and synaptic mechanisms are highly
integrative and suggest that this relationship fundamentally ex-
ists at the level of transcriptional co-expression, at least in the
striatum. Because mitochondrial and synaptic impairment is
characteristic of CNS diseases, it is particularly interesting that
the Turquoise module is most relevant to both behavioral re-
sponses to novel environment and REM sleep after acute
restraint stress. Specifically, increased module expression cor-
relates with increased anxiety measures, as well as increased
REM bouts and decreased median inter-REM interval in the first
half of the dark period after restraint stress (Table S5). Transcrip-
tional co-regulation of mitochondrial and synaptic genes may
provide a mechanistic basis for the comorbidity of anxiety,
stress-related REM sleep disruptions, and neuropathology.
Bayesian Network Reconstruction Identifies Key Driver
Genes Linking Sleep and Stress
We used Bayesian network reconstruction to calculate causal
probabilistic relationships between genes and identify the causal
regulators (i.e., key drivers) of transcriptional networks linking
stress and sleep traits. We utilized cis-eQTL (FDR < 0.1) as
causal anchors in our directed probabilistic network and recon-
structed a single consensus Bayesian network from 18,460
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Figure 5. Identification of Gene Co-expression Modules Relevant to Selected Behavioral and Sleep Phenotypes
(A) The topological overlap matrix (TOM) plot corresponds to the striatal gene co-expression network. Darker color indicate stronger co-regulation between a pair
of genes (in rows and columns). Genemodules are identified by hierarchical clustering of the matrix, as labeled by arbitrarily assigned color bars on the top and at
the left.
(B) Identification of modules (rows) significantly associated with selected phenotypes (columns) organized in categories. Gene modules are indicated by their
assigned color at the left. Red bars indicate significant associations (p < 0.05 and FDR < 0.05).
(C) Ranking of modules (rows) based on relevance to individual phenotypic categories and combined categories of interest (columns). Module rankings for a
phenotypic category were determined by the number of significant module-trait associations within the phenotypic category. For a combination of multiple
phenotypic categories, rankings for each category were summed to determine a composite ranking for each module. Darker color indicate higher ranking. The
actual rankings are also labeled.
BL, baseline sleep; SDR, sleep deprivation recovery; Rst, sleep after restraint stress.genes with the greatest variance across the mouse population
(Supplemental Experimental Procedures). We intersected the
full Bayesian network with the Turquoise module and identified
the key driver genes that primarily control the expression of the
module. Our agnostic approach identified many key drivers
that have been supported by other experiments. For instance,
we identified Slc17a7, Fmr1, and Grm5 as striatal key drivers,
which have previously been implicated in regulating anxiety-
related behavior (Moy et al., 2009; Tordera et al., 2007; Vartyet al., 2005). We also identified Syngr1 as a key driver, which is
differentially regulated in an animal model of depression (Kroes
et al., 2006) and has been genetically linked to panic disorder
in humans (Hamilton et al., 2003). Furthermore, another key
driver of the module, Pde10a (phosphodiesterase 10A), was re-
ported as a candidate genes for conduct disorder (Dick et al.,
2011) and has been tested as an antipsychotic target in animal
models (Smith et al., 2013). Our results offer tissue-specific res-
olution, suggesting that the transcriptional actions of these keyCell Reports 11, 835–848, May 5, 2015 ª2015 The Authors 841
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Figure 6. Striatal Bayesian Networks
Downstream of Mical2
Each node represents a gene and each directed
edge indicates a causal link between genes. No-
des are colored according to their module as-
signments, using the names of the respective
modules. Key driver genes are represented by
larger square nodes. Nodes with red rims denote
homologs of human GWAS candidates for
neuropsychiatric disorders, and nodes with yel-
low rims denote candidate genes identified in this
study as causal to stress and sleep phenotypes.
One node is labeled with a half red and half yellow
rim, as the represented gene (St8sia2) is a both
reported GWAS candidate for bipolar disorder
and tested causal to a REM sleep phenotype in
this study.drivers in the striatum may contribute to the emergence of these
anxiety-related traits in animal models and relevant psychiatric
disorders in humans.
Since the Turquoise module is enriched with causal genes for
anxiety-like behaviors, we investigated the organization of these
causal genes in the subnetwork and found that two causal candi-
dates in the Turquoise module, Cadm2 and Kcnj9, are also key
drivers.Kcnj9 encodesGIRK3, a subunit of G-protein-dependent
inwardly rectifying K+ channels. GIRK channels have been impli-
cated in a variety of diseases, including anxiety (Pravetoni and
Wickman, 2008) and addiction (Morgan et al., 2003). GIRK3 in
particular is thought to modulate the availability of all GIRK chan-
nels on the plasma membrane through lysosomal trafficking and
thus may be key to GIRK-related disease mechanisms (Lu¨scher
and Slesinger, 2010). Interestingly, GIRK3 (Kcnj9) is immediately842 Cell Reports 11, 835–848, May 5, 2015 ª2015 The Authorsdownstream of another key driver gene,
Mical2 (a microtubule associated mono-
oxygenase), in its transcriptional subnet-
work (Figure 6). Molecularly, MICALs
link cytoskeletal dynamics, synaptic
structure, vesicle trafficking, and redox
signaling (Zhou et al., 2011). They also
bindCasL, alleles ofwhichare associated
with neurological disease (Li et al., 2008).
By regulating the expression of Kcnj9,
Mical2 drives a metabotropic glutamate
receptor (Grm2), which has been impli-
cated in anxiety (Galici et al., 2006).
Mical2 is also upstream of a GABAB re-
ceptor (Gabbr2), whose physiological
properties are intimately linkedwith those
of GIRK receptors (Lu¨scher and Sle-
singer, 2010). Furthermore, Mical2 is
immediately upstream of several mito-
chondrial genes, including Dlc1, which
is responsible for Bcl-2-activated
mitochondrial-mediated apoptosis, and
Nuak1, which controls synaptic plasticity
and axon branching dependent on mito-
chondria mobilization (Courchet et al.,2013; Sunet al., 2013). Taken together, this subnetwork suggests
thatMical2may serve as a striatal regulator of synaptic andmito-
chondrial pathways and contribute to mechanisms fundamental
to sleep, stress, and neuropathology.
Key Driver Nodes of Stress and Sleep Subnetworks Are
Implicated in Neuropsychiatric Diseases
Since the Turquoise module is strongly associated with anxiety-
related traits in mice, we investigated whether its key drivers
have been previously implicated in neuropsychiatric disease in
humans. We queried the National Human Genome Research
Institute Catalog of Published Genome-Wide Association
Studies (GWAS) (Welter et al., 2014) for candidate genes associ-
ated with neuropsychiatric disorders (Table S5). Interestingly,
mouse homologs of these GWAS genes are overrepresented in
Gan
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Chodl
Gm16154
Dync1h1
Vps13d
Htt
Wdr7
Figure 7. Striatal Bayesian Networks Downstream of Htt and Bsn
Each node represents a gene and each directed edge indicates a causal link
between genes. Nodes are colored according to their module assignments,
using the names of the respective modules. Key driver genes are represented
by larger square nodes.the Turquoise module (p = 2.983 105, 1.3x) and are more likely
to overlap with the key drivers of the module than with down-
stream module genes (p = 0.02, 1.8x). Since GWAS data lack
mechanistic information, our results contextualize human
gene-phenotype associations within a causal probabilistic
model with tissue-specific resolution. Interestingly, key drivers
of the Turquoise module are not exclusively related to neuropsy-
chiatric diseases. Its key drivers are also overrepresented for
genes involved in Parkinson’s disease (p = 0.01, 6.6x) and Hun-
tington’s disease (p = 0.069, 4.8x) according to the KEGG (Kyoto
Encyclopedia of Genes and Genomes) database. Taken
together, these results suggest that genes associated with
neurological and psychiatric diseases are important regulators
of subnetworks linking stress and sleep traits.
The Mediumpurple2 Module Reveals Links between
Stress, Sleep, and Neurodegeneration
Links between neurodegeneration and key drivers of stress/
sleep gene networks are not limited to the Turquoise module.The Mediumpurple2 module also links neurodegeneration to
stress and sleep. It has the highest composite ranking for forced
swim measures (fifth), sleep fragmentation traits at baseline
(third), and after sleep deprivation (fourth) (Figure 5C). This mod-
ule is enriched for the chromatin-modification GO category (p =
9.78 3 107, 5.7x), suggesting transcriptional control of chro-
matin-modifying genesmay link depressive behaviors with sleep
fragmentation.While theMediumpurple2module ranks highly for
sleep fragmentation measures at baseline and after sleep depri-
vation, it ranks poorly for sleep fragmentation after restraint
stress (15th). Such stressor-specific module-trait relationships
are also observed in other modules, including the White module,
which is specifically associated with sleep fragmentation after
sleep deprivation, and theMidnightblue module, which is specif-
ically associated with sleep fragmentation after the restraint
stress. It is well known that different stressors correlate with
different physiological sleep changes (Suchecki et al., 2012),
and these stressor-specific sleep modules, which include
Mediumpurple2, suggest that this phenomenon is also apparent
on the gene network level.
In addition to its stressor-specific relationships to sleep phe-
notypes, theMediumpulple2 module is also linked with neurode-
generation. Key driver genes of the Mediumpurple2 subnetwork
include Htt, whose polyQ expansion causes Huntington’s
disease. Other Mediumpurple2 key drivers such as Bsn, Mll1,
and Celsr3 have also been associated with ataxia, epilepsy,
and neurodegeneration (Altrock et al., 2003; Lim et al., 2009; Tis-
sir et al., 2005). The Htt and Bsn subnetworks converge to drive
the expression of the gene encoding heavy-chain of cytoplasmic
dynein,Dync1h1 (Figure 7), whosemutations have been linked to
Huntington’s disease-like striatal atrophy and metabolic defects
(Braunstein et al., 2010; Eschbach et al., 2011). We found that
37%of the key drivers in this module are genes that causemotor
abnormalities when disrupted, as cataloged by the Mouse
Genome Database (Blake et al., 2014). This network enrichment
(p = 8.4 3 104, 6.56x) suggests that genes classically associ-
ated with neurological disease drive subnetworks shared by
stress and sleep traits. Patients of neurodegenerative diseases
concomitantly suffer from psychiatric and sleep disorders
(Morton, 2013; Sauerbier and Ray Chaudhuri, 2014), which often
precede the disease onset (Postuma et al., 2012; Shirbin et al.,
2013). While links between stress and neurodegeneration
have been hypothesized (Kibel and Drenjancevic-Peric, 2008),
studies on their connections at the genetic and molecular
level are limited. Our results thus suggests that biological
mechanisms linking stress, sleep, and neurodegeneration may
reside fundamentally in the network organization of striatal
gene expression.
DISCUSSION
Sleep-wake and stress traits are controlled by complex genetic
architectures (Feder et al., 2009; O’Hara et al., 2007). Here, we
combined amultiscale systems approach with extensive pheno-
typing to investigate how genetic variation and transcriptional
networks contribute to the emergence of multiple sleep and
stress phenotypes. We uncovered candidate genes underlying
the associations between genetic and phenotypic variationsCell Reports 11, 835–848, May 5, 2015 ª2015 The Authors 843
using a causality test, but noted that this gene-level approach
was limited. Consequently, we demonstrated that network-level
analysis better captures the effect of numerous loci on the orga-
nization of transcriptional networks and the emergence of com-
plex interacting phenotypes. Since stress maladaptation and
sleep disturbance may precede and predispose patients to
neuropsychiatric disease, understanding their molecular inter-
sections is critical for developing a more sophisticated and
nuanced conception of disease mechanism, progression, and
therapeutic intervention (Goldstein and Walker, 2014). Our anal-
ysis indeed revealed that key drivers regulating sleep- and
stress-related transcriptional networks are functionally impor-
tant and significantly overlap with genetics associated with
human neuropsychiatric diseases. This result not only contextu-
alizes GWAS findings, but also suggests that the seemingly
discrete GWAS genes can be functionally linked via gene regula-
tory networks important for stress and sleep. Furthermore, the
broad overlaps between neuropsychiatric GWAS candidates
and key drivers of stress/sleep gene networks support the
concept that gene network structure can be used to predict
functional consequences produced by molecular perturbations.
We have highlighted several module-trait relationships that
link sleep, stress, and neuropsychiatric disease. In this article,
we highlight the co-expression of mitochondrial and synaptic
genes and their relationship to anxiety-related behaviors and
REM sleep traits after restraint stress. Since both sleep and
stress disorders are common in many psychiatric diseases,
these molecular networks can provide insights into the onset
and maintenance of neuropsychopathology. We also provide
a full catalog of all module-traits relationships (Table S5) as
a resource that can facilitate in silico hypothesis testing and
in vivo validation of potential molecular mechanisms and
therapeutic candidates relevant for chronic stress, sleep,
and neuropathology.
Impaired mitochondrial and synaptic functions, similar to
sleep dysfunction and stress susceptibility, are commonly linked
with many neurological and psychiatric diseases. However,
studies of the interaction between mitochondrial and synaptic
pathways and its role in disease have produced conflicting and
sometimes tenuous evidence, which speaks to the complexity
of the biology and its consequent pathophysiology. Studying in-
dividual genes and pathways insufficiently explains this complex
relationship, so a systems approach is ideal for identifying the
basis of this interaction (Manji et al., 2012). In the present study,
the Bayesian network reconstruction revealed many key driver
genes that regulate both mitochondrial and synaptic pathways
and may serve as potential therapeutic targets for human neuro-
psychiatric disorders. Mical2 is one particularly interesting
example since it links multiple pathways related to CNS dis-
eases. Although the molecular function of Mical2 in mammals
has not been extensively characterized, several independent
lines of evidence support the role ofMical2 in mediating anxiety
behaviors and neuropathology. The expression of Mical2 is
downregulated in patients of major depressive disorder (Tochigi
et al., 2008), in stress-susceptible rats after chronic restraint
stress (Crews et al., 2012), and in offspring of prenatally stressed
rats (Mychasiuk et al., 2011).Mical2 was also identified as a hub
gene in a co-expression module implicated in human autism844 Cell Reports 11, 835–848, May 5, 2015 ª2015 The Authorsspectrum disorder (Parikshak et al., 2013), which has a signifi-
cant anxiety/phobia component. Our analyses converge with
these previous studies and provide strong evidence for the role
of Mical2 in neuropsychiatric disease. Importantly, therapeutics
targeting mitochondrial and synaptic pathways have been suc-
cessful for treating CNS diseases and may represent an impor-
tant direction for developing treatment for a range of neurological
and psychiatric disorders (Manji et al., 2012). Therefore, the
key drivers of the mitochondria/synaptic subnetwork represent
strong therapeutic candidates, as exemplified by Pde10a, a
pharmacological target for psychotic disorders (Smith et al.,
2013).
In the present study, we examined the striatum because it is
critical for regulating motivation, stress susceptibility, and sleep
and is dysfunctional in many neuropsychiatric diseases. Our
integrative analysis revealed that striatal gene networks are
extensively shared by sleep and stress phenotypes and that
these points of intersection are relevant to neuropsychiatric
disease. However, many other brain regions are known to be
involved in the regulation of stress and/or sleep. It is likely
that coordinated organization and functionality of gene net-
works in multiple brain regions are required for appropriate
stress adaptation and sleep regulation. Limited to only one
brain region, our current analysis does not address tissue spec-
ificity or multi-tissue coordination of gene networks relevant to
stress and sleep. Since we collected other brain regions and
peripheral organs in our chronically stressed and extensively
phenotyped (B6 3 A/J) F2 mouse population, we are in a posi-
tion to extend our systems approach to multiple tissues in
future studies.
Finally, our data-driven systems approach has revealed a
number of intriguing but unexpected results. For example, we
found that key drivers of multiple networks linking sleep and
stress are enriched with neurodegenerative genes, suggesting
amolecular mechanism linking stress, sleep, and neurodegener-
ation. The frequency of this association in our networks suggests
that neurodegenerative properties may be a general attribute of
key driver nodes important for both stress and sleep, at least in
the striatum, a brain region known to be prone to neurodegener-
ative diseases such as Huntington’s and Parkinson’s diseases.
This hypothesis requires further investigation but proposes that
identifying common networks relevant to stress and sleep can
reveal molecular mechanisms and therapeutic targets of neuro-
pathology. Furthermore, although the main text of this paper
focuses on 15 categories of phenotypes most relevant to the
striatum, our data-driven approach can also be applied to the
other 14 categories of phenotypes that are not classically asso-
ciated with striatal function. As expected, the neuronal-specific
module Turquoise is almost exclusively associated with sleep
and behavioral phenotypes and is not associated with pheno-
types that do not directly involve the CNS, confirming the
functional specificity of gene network organization. However, a
number of associations between other striatal gene modules
and non-CNS phenotypes were also observed. For instance,
the modules enriched for cellular for stress response genes
(Indianred4) and chromatin-modification genes (Mediumpur-
ple2) ranked the highest for peripheral white blood cell measure-
ments, whose association with the striatum is unknown. Some
evidence suggests that the peripheral immune system plays an
important role in stress resilience, cognition, and other central
nervous system functions (Cohen et al., 2006; Kipnis et al.,
2012; Schwartz and Kipnis, 2011), and our unbiased analyses
support this link by showing that serological measurements of
the peripheral immune system correlate with striatal transcrip-
tional networks that are also associated with stress-related
behavioral and sleep phenotypes. The precise relationship be-
tween the striatum and peripheral immune system is beyond
the scope of this study, but this analysis can serve as comple-
mentary evidence for future investigations regarding the interac-
tions between the functions of multiple organ systems involved
in stress and sleep.
Overall, our analysis provides the foundation for a data-driven
approach that links diverse phenotypes through common mo-
lecular networks, and our strategy considers the complex symp-
tomatology of neuropsychiatric disease as a guide, rather than a
hindrance, to our molecular analysis. We provide all the data and
analysis results as a resource to the biomedical research com-
munity, and we expect it will guide future investigations into
the biological mechanisms underlying stress, sleep, and related
neuropathology.
EXPERIMENTAL PROCEDURES
Animals and Housing
All mice were housed and handled according to the Federal Animal Welfare
guidelines, and all studies were approved in advance by the Institutional Ani-
mal Care and Use Committee at Northwestern University. This study utilized
338 male (B63 A/J) F2 mice, bred at the Jackson Laboratory. Animals arrived
at Northwestern at 4 to 5 weeks of age and were individually housed in opaque
cages without enrichment items for the duration of the study to create social
isolation stress. Mice were maintained on a 12-hr light/12-hr dark cycle at a
room temperature of 23C ± 2C with food and water available ad libitum
(except during test procedures).
Stress Procedures and Phenotypes
Mice were divided into 12 consecutively run cohorts of 10–40 animals each,
which were all subjected to the same chronic unpredictable stress protocol
(Figure 1A) with accompanying phenotypic measurements (see Supple-
mental Experimental Procedures). The stressors included social isolation,
novel exposed environments (elevated plus maze, open field, elevated zero
maze), restraint, forced swimming, fear conditioning, social defeat, cold
exposure, a metabolic stressor (6-hr fast and glucose tolerance test), and
the sleep behavior response to sleep deprivation and restraint. Sleep/wake
behavior was recorded from each mouse by surgically implanting EEG and
EMG electrodes. Following all stress and sleep behavior tests, all animals
were euthanized by decapitation, and blood and tissue samples were
collected for additional analyses. Phenotypes were functionally grouped
into 29 categories; for sleep traits, factor analysis was used to confirm cat-
egories (Table S1).
Genotyping
Genotypes of all animals were determined from DNA extracted from tail-tip bi-
opsies by using the Illumina medium-density single-nucleotide polymorphism
(SNP) panel. A complete set of the genotypic data is provided in Table S1.
RNA-Seq
The striatum brain region was rapidly dissected from each mouse after eutha-
nasia and frozen in liquid nitrogen. Gene expression from the striatum was
evaluated using RNA sequencing; 100-bp single-end sequencing reads
were aligned against the Ensembl NCBIM37 mouse reference genome for
gene-level expression profiling.Analysis Procedures
Details of analysis procedures are described in the Supplemental Experi-
mental Procedures. Briefly, for the genome-wide QTL and eQTL scan, we
used Haley-Knott (HK) regression in the r/qtl package. The sample order of
the genotypic data was randomly permuted 1,000 times to estimate FDRs
for phenotypic QTL. FDRs for cis-eQTL and trans-eQTL were separately esti-
mated based on 500 permutations.
In the causality test, we consider combinations of a trait (T), expression of a
gene (G), and a locus (L) regulating both T and G. G tests causal to T if the
following four conditions are met: (1) L is associated with T, (2) L is associated
with GjT, (3) G is associated with TjL, and (4) L is independent of TjG.
To construct co-expression networks, we used a weighted gene co-expres-
sion network analysis (WGCNA) framework, in which gene expression correla-
tions were weighted with a positive power in order to satisfy a ‘‘scale-free’’
power law connectivity distribution in the resulting network. Genes were then
grouped into modules using hierarchical clustering based on their topological
overlap.Geneexpression inamodulewas reduced to their firstprincipal compo-
nent and correlated with phenotypes to identify module-trait relationships.
Bayesian network reconstruction was used to decipher regulatory relation-
ships among genes. To breakMarkov equivalent structures and infer causality,
cis-eQTL data were used as causal anchors. We used a Monte Carlo Markov
Chain (MCMC) simulation to reconstruct 1,000 gene networks, evaluating the
fit of each network with Bayesian Information Criterion (BIC). A single
consensus network was constructed from these simulations and was used
to identify key regulators of modules relevant to sleep and stress traits. We
calculated the size of the h-layer neighborhood (HLN) downstream of each
gene in the subnetwork resulting from the intersection between Bayesian
network and the module. Genes were identified as causal network regulators
(i.e., key drivers) if their HLNs are greater than mean(m) + s(m), where m is the
size of the respective HLN of each gene in the subnetwork.
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